Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Biodesix Inc (NQ: BDSX )

1.250 +0.010 (+0.81%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 8,416
Open 1.230
Bid (Size) 1.240 (5)
Ask (Size) 1.250 (8)
Prev. Close 1.240
Today's Range 1.230 - 1.250
52wk Range 1.030 - 2.210
Shares Outstanding 78,614,114
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Biodesix to Report First Quarter 2024 Financial Results on May 8, 2024
From Biodesix, Inc.
Via Business Wire
Biodesix to Present New Data on Liquid Biopsy Technologies at AACR 2024 Annual Meeting
From Biodesix, Inc.
Via Business Wire

Performance

YTD
-29.78%
-29.78%
1 Month
-14.97%
-14.97%
3 Month
-37.19%
-37.19%
6 Month
-11.97%
-11.97%
1 Year
-24.70%
-24.70%

More News

Read More
S&P 500 Gains Over 1%; GCT Semiconductor Shares Spike Higher
Via Benzinga
Topics Stocks
Exposures US Equities
Biodesix Reports 65% Growth In Lung Diagnostic Test Volume In Q4
Via Talk Markets
Biodesix: Q4 Earnings Insights
Via Benzinga
Biodesix's Earnings Outlook
Via Benzinga
Why Byrna Technologies Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Gold Surges Over 1%; Biodesix Shares Plummet
Via Benzinga
Topics Stocks
Exposures US Equities
Dow Jumps Over 100 Points; US Economy Adds 303,000 Jobs In March
Via Benzinga
Topics Economy Stocks
Exposures Economy US Equities
Recap: Biodesix Q3 Earnings
Via Benzinga
Biodesix Announces Pricing of Oversubscribed and Upsized Underwritten Offering of Common Stock and Concurrent Private Placement
From Biodesix, Inc.
Via Business Wire
Biodesix Announces New Master Collaborative Research Agreement with Leading US Cancer Center
From Biodesix, Inc.
Via Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Earnings Scheduled For March 1, 2024
Via Benzinga
Biodesix Announces Fourth Quarter and Fiscal Year 2023 Results and Business Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in the TD Cowen 44th Annual Health Care Conference
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Fourth Quarter and Full Year 2023 Financial Results on March 1, 2024
From Biodesix, Inc.
Via Business Wire
3 Penny Stocks to Turn $999 Into $1 Million: January 2024
Via InvestorPlace
Topics Economy
Exposures Economy
Biodesix Enhances Access to Nodify Lung® Testing with Launch of New Blood Draw Method
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in November
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Third Quarter 2023 Results and Highlights
From Biodesix, Inc.
Via Business Wire
Biodesix to Report Third Quarter 2023 Financial Results on November 7, 2023
From Biodesix, Inc.
Via Business Wire
Biodesix to Present New Data on Nodify Lung® Testing at CHEST 2023 Annual Meeting
From Biodesix, Inc.
Via Business Wire
Biodesix Announces Two Presentations on Lung Cancer Treatment Guidance Tests at the IASLC 2023 World Lung Conference on Lung Cancer
From Biodesix, Inc.
Via Business Wire
Biodesix to Participate in Two Upcoming Investor Conferences in September
From Biodesix, Inc.
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.